Related Experiment Video
Updated: Jun 27, 2026

08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
From Primary Melanoma to Metastatic Evolution: AI-Powered Pathology Integrated with Functional Analysis and Clinical
Lívia Fülöp1, Leticia Szadai2,3, Balazs Szigeti1
1National Kerenyi Institute of Pulmonology, 1122 Budapest, Hungary.
Cancers
|June 26, 2026
Summary
Understanding melanoma tumor evolution is key for effective treatment. This study introduces multimodal disease profiling, integrating proteogenomics and AI pathology, to create dynamic patient models for precision melanoma care.
Area of Science:
- Oncology
- Bioinformatics
- Medical Imaging
Background:
- Current melanoma treatment lacks a comprehensive understanding of tumor evolution.
- Clinical complexity necessitates advanced, biologically informed decision-support tools.
- Integrating diverse data is crucial for personalized melanoma management.
Purpose of the Study:
- To implement a multimodal disease profiling framework for melanoma patient treatment optimization.
- To enhance clinical decision-making across the entire disease course.
- To develop patient-specific models for tracking tumor evolution and treatment response.
Main Methods:
- Integrating proteogenomics to analyze tumor signaling and protein dynamics.
- Utilizing AI-driven digital image analysis for pathology and immune context assessment.
- Combining proteogenomic, imaging, and longitudinal clinical data for a holistic view.
Main Results:
- Proteogenomics identifies vulnerabilities driving melanoma progression and resistance.
- AI pathology captures spatial and functional changes related to metastasis.
- Integrated data enables patient-specific models of tumor evolution and treatment exposure.
Conclusions:
- Multimodal disease profiling provides a dynamic, evolving view of melanoma.
- This framework supports precision melanoma care through biologically grounded decision support.
- It facilitates prediction of treatment response, resistance, and disease trajectory for adaptive therapy.

